CINECA IRIS Institutional Research Information System

FALCONE, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.218
AS - Asia 8.159
EU - Europa 3.933
SA - Sud America 1.798
Continente sconosciuto - Info sul continente non disponibili 535
AF - Africa 337
OC - Oceania 26
Totale 33.006
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.689
SG - Singapore 2.984
HK - Hong Kong 1.595
CN - Cina 1.577
BR - Brasile 1.410
IT - Italia 1.218
VN - Vietnam 703
BG - Bulgaria 515
SE - Svezia 473
DE - Germania 367
CA - Canada 310
GB - Regno Unito 304
FR - Francia 273
IN - India 258
RU - Federazione Russa 230
TR - Turchia 206
JP - Giappone 132
BD - Bangladesh 130
FI - Finlandia 130
AR - Argentina 109
IQ - Iraq 100
MX - Messico 72
CI - Costa d'Avorio 67
NL - Olanda 64
VE - Venezuela 63
ZA - Sudafrica 63
SA - Arabia Saudita 62
EC - Ecuador 54
KR - Corea 53
PK - Pakistan 53
AT - Austria 50
CO - Colombia 48
ES - Italia 48
PL - Polonia 48
ID - Indonesia 47
MA - Marocco 39
PH - Filippine 35
UA - Ucraina 35
JM - Giamaica 34
CZ - Repubblica Ceca 32
KE - Kenya 32
UZ - Uzbekistan 31
CL - Cile 29
CH - Svizzera 28
SN - Senegal 28
PY - Paraguay 26
JO - Giordania 25
AE - Emirati Arabi Uniti 23
TN - Tunisia 22
EG - Egitto 21
PE - Perù 21
UY - Uruguay 21
AU - Australia 19
CR - Costa Rica 19
IE - Irlanda 19
TT - Trinidad e Tobago 17
NG - Nigeria 16
NP - Nepal 16
AZ - Azerbaigian 14
HU - Ungheria 13
HN - Honduras 12
IL - Israele 12
MY - Malesia 12
NI - Nicaragua 12
BE - Belgio 11
DZ - Algeria 11
ET - Etiopia 11
GT - Guatemala 11
KZ - Kazakistan 11
AL - Albania 10
BO - Bolivia 10
LT - Lituania 9
PS - Palestinian Territory 9
DO - Repubblica Dominicana 8
IS - Islanda 8
OM - Oman 8
BB - Barbados 7
EU - Europa 7
GE - Georgia 7
LY - Libia 7
PA - Panama 7
AO - Angola 6
LB - Libano 6
NZ - Nuova Zelanda 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
SV - El Salvador 6
TW - Taiwan 6
BH - Bahrain 5
GR - Grecia 5
MD - Moldavia 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
BY - Bielorussia 4
GY - Guiana 4
IR - Iran 4
KH - Cambogia 4
KW - Kuwait 4
KG - Kirghizistan 3
PR - Porto Rico 3
Totale 32.413
Salva come PNG Salva come JPEG
Città #
Ashburn 1.887
Singapore 1.734
Hong Kong 1.588
Dallas 1.559
Fairfield 1.208
San Jose 1.001
Santa Clara 934
Chandler 656
Shanghai 598
Woodbridge 555
Boulder 524
Seattle 519
Sofia 514
Houston 480
Council Bluffs 432
New York 427
Wilmington 415
Cambridge 407
Los Angeles 327
Boardman 302
Milan 274
Beijing 267
Princeton 231
Lawrence 215
Lauterbourg 199
Ho Chi Minh City 176
Des Moines 165
Ann Arbor 156
Medford 153
Istanbul 142
Hanoi 134
Ottawa 134
Florence 126
Munich 120
São Paulo 120
Tokyo 111
Buffalo 107
London 102
Redondo Beach 93
Frankfurt am Main 90
San Diego 89
Pisa 79
Chicago 69
Rome 69
Abidjan 67
Helsinki 67
Dong Ket 62
Atlanta 61
Elk Grove Village 60
Serra 54
Bremen 52
Ogden 52
Rio de Janeiro 52
Columbus 51
Montreal 50
Denver 49
Nanjing 47
Seoul 47
Hefei 46
Nuremberg 43
San Francisco 42
Baghdad 41
Brooklyn 41
Turku 41
Belo Horizonte 40
Orem 39
Toronto 38
Hyderabad 37
The Dalles 36
Warsaw 36
Vienna 35
Brasília 34
Phoenix 33
Stockholm 33
Dakar 28
Nairobi 28
Pune 28
Tashkent 27
Brno 25
Dhaka 25
Haiphong 25
Hebei 25
Johannesburg 25
Kingston 25
Da Nang 24
Redwood City 24
Curitiba 23
Riyadh 23
Nanchang 22
Amman 21
Fuzhou 21
Porto Alegre 21
Changsha 20
Guayaquil 20
Tianjin 20
Baltimore 19
Chennai 19
Jeddah 19
Manchester 19
Zurich 19
Totale 21.469
Salva come PNG Salva come JPEG
Nome #
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 964
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 426
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases 379
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study 237
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) 228
Predictors and outcomes of respiratory bacterial coinfections in patients with COVID-19 admitted to hospital: An observational prospective study 227
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients 226
Clinical features and outcomes of infections caused by metallo-β-lactamases producing Enterobacterales: a 3-year prospective study from an endemic area 222
Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study 204
Current role of ceftobiprole in the treatment of hospital-acquired and community-acquired pneumonia: expert opinion based on literature and real-life experiences 203
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody 202
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 200
Salvage therapy with sulbactam/durlobactam against cefiderocol-resistant Acinetobacter baumannii in a critically ill burn patient: clinical challenges and molecular characterization 197
Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update 197
Risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) infections in critically ill patients with previous CRAB colonization: a multicentre cohort study 192
A rare case of mycobacterial pseudoaneurysm of the superficial femoral artery 189
What is the clinical significance of 'heteroresistance' in nonfermenting Gram-negative strains? 186
Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019 186
Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19 184
Therapeutic drug monitoring of antibiotics for methicillin-resistant Staphylococcus aureus infections: an updated narrative review for clinicians 182
Pharyngeal and cutaneous diphtheria: a tail of a refugee 179
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: A multicenter study 177
Physical, Mental and Sexual Health Among Transgender Women. A comparative Study Among Operated Transgender and Cisgender Women in a National Tertiary Referral Network 175
Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-Negative infections in ICU patients 174
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 167
A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy 166
The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy 161
Predictors of mortality in solid-organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: the impact of cytomegalovirus disease and lymphopenia 159
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study) 158
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience 156
High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis 153
Combination of aspirin plus macrolides in patients with severe community-acquired pneumonia: a hypothesis-generating study 151
Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community-acquired Pneumonia 150
Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study 149
Healthcare-associated pneumonia: a never-ending story 148
Healthcare-associated pneumonia and multidrug-resistant bacteria: Do we have a convincing answer? 146
Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases 146
Comparison of different microbiological procedures for the diagnosis of Pneumocystis jirovecii pneumonia on bronchoalveolar-lavage fluid 146
Worrisome trend of new multiple mechanisms of linezolid resistance in staphylococcal clones diffused in Italy 145
Clinical experience of anidulafungin for the treatment of patients with documented candidemia 144
Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis 144
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey 143
Candidaemia after heart valve replacement surgery: recurrence as prosthetic valve endocarditis is an expected over one-year complication 143
Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link? 143
Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities 142
Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia 141
Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter SEI cohort 141
Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie’s disease in a multicenter clinical study 141
Low diaphragm muscle mass predicts adverse outcome in patients hospitalized for COVID-19 pneumonia: An exploratory pilot study 140
The S862C amino acid change in CpMrr1 confers fluconazole resistance in Candida parapsilosis 139
Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis 138
Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis 138
Is NOX2 Upregulation Implicated in Myocardial Injury in Patients with Pneumonia? 137
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial 137
Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study 137
Invasive aspergillosis in patients with liver disease 136
Diabetes and acute bacterial skin and skin structure infections 136
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae 136
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 136
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii 136
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience 135
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 135
Platelet activation is associated with myocardial infarction in patients with pneumonia 135
Impact of Initial Antifungal Therapy on the Outcome of Patients With Candidemia and Septic Shock Admitted to Medical Wards: A Propensity Score-Adjusted Analysis 135
Native-Valve Aspergillus Endocarditis: Case Report and Literature Review 133
Surveillance and management of multidrug-resistant microorganisms 133
In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes 132
Simplified Equations Using Two Concentrations To Calculate Area under the Curve for Antimicrobials with Concentration-Dependent Pharmacodynamics: Daptomycin as a Motivating Example 132
Cirrhotic patients are at risk for health care-associated bacterial infections 132
Early, intermediate and late infectious complications after transcatheter or surgical aortic-valve replacement: a prospective cohort study 131
Candidal thrombophlebitis of central veins: case report and review 131
Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events 131
Pneumonia in frail older patients: An up to date 130
Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience 130
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern 130
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: An observational study from Italy, 2020-21 130
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 129
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients 129
Paradigm Shift: Candida parapsilosis sensu stricto as the Most Prevalent Candida Species Isolated from Bloodstream Infections with Increasing Azole-Non-Susceptibility Rates: Trends from 2015–2022 Survey 129
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 128
Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections 128
Performance status and in-hospital mortality of elderly patients with community acquired pneumonia 128
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae 127
Left Atrium Dilatation and Left Ventricular Hypertrophy Predispose to Atrial Fibrillation in Patients With Community-Acquired Pneumonia 127
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality 127
Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study 127
Pretomanid for tuberculosis treatment: an update for clinical purposes 126
Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy 126
Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: new insights and evidence from the literature 126
Updates in the epidemiology and management of candidemia and Clostridioides difficile coinfection 126
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients with COVID-19 Pneumonia: A Randomized Clinical Trial 125
Candidemia Subsequent to Severe Infection Due to Clostridium difficile: Is There a Link? 124
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia 124
Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections 123
Low-grade endotoxemia and clotting activation in the early phase of pneumonia 123
Early identification of severe community-onset pneumonia in "frail elderly patient" 123
Conservative medical therapy of infections following osteosynthesis: A retrospective analysis of a six-year experience 122
Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection 122
Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for Treating Enterococcus faecalis Infective Endocarditis 121
CAP and HCAP are different? An unresolved question 121
Totale 16.291
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.751
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.928 0 0 69 98 381 312 125 126 101 43 149 524
2022/20232.273 295 188 161 209 264 340 35 190 365 10 172 44
2023/20241.746 118 141 153 94 236 369 147 50 31 16 114 277
2024/20257.968 59 304 66 477 585 841 631 367 758 954 719 2.207
2025/20269.842 510 920 1.426 1.272 893 823 1.323 436 700 844 434 261
2026/20273.800 574 2.038 1.188 0 0 0 0 0 0 0 0 0
Totale 33.006